Aphidicolin-induced nuclear elongation in tobacco BY-2 cells.
Plant nuclei are known to differentiate into various shapes within a single plant. However, little is known about the mechanisms of nuclear morphogenesis. We found that nuclei of tobacco BY-2 cells were highly elongated on long-term treatment with 5 mg l⁻¹ aphidicolin, an inhibitor of DNA polymerase α. In aphidicolin-treated cells, the nuclear length was correlated with the cell length. During culture in the presence of aphidicolin, the nuclei were elongated in parallel with cell elongation. Nuclear elongation was inhibited by the inhibition of cell elongation with 2,6-dichlorobenzonitrile, a cellulose synthesis inhibitor. However, cell elongation induced in the auxin-depleted medium in the absence of aphidicolin did not cause nuclear elongation, indicating that cell elongation alone is not sufficient for nuclear elongation. Treatment with either latrunculin B or propyzamide inhibited the aphidicolin-induced nuclear elongation, indicating that both actin filaments and microtubules (MTs) are required for nuclear elongation. Observations using BY-YTHCLR2 cells, in which actin filaments, MTs and nuclei were simultaneously visualized, revealed that the longitudinally arranged MT bundles associated with the nucleus play an important role in nuclear elongation, and that actin filaments affect the formation of these MT bundles. In aphidicolin-treated cells, the nuclear DNA contents of the elongated nuclei exceeded 4C, and the nuclear length was highly correlated with the nuclear DNA content. In cells treated with 50 mg l⁻¹ aphidicolin, cells were elongated and nucleus-associated longitudinal MT bundles were formed, but the nuclear DNA contents did not exceed 4C and the nuclei did not elongate. These results indicate that an increase in the nuclear DNA content above 4C is also required for nuclear elongation.
Department of Life Science and Biotechnology, Faculty of Chemistry, Materials and Bioengineering, Kansai University, Suita, Osaka, 564-8680 Japan.
Hiroki
H
Yasuhara
Kazuki
K
Kitamoto
D008841:Actin Cytoskeleton / Q000187:drug effects / Q000378:metabolism; D016590:Aphidicolin / Q000494:pharmacology*; D001549:Benzamides / Q000494:pharmacology; D019086:Bridged Bicyclo Compounds, Heterocyclic / Q000494:pharmacology; D002460:Cell Line; D002467:Cell Nucleus / Q000187:drug effects* / Q000235:genetics / Q000502:physiology*; D048429:Cell Size / Q000187:drug effects; D003599:Cytoskeleton / Q000187:drug effects / Q000378:metabolism; D018744:DNA, Plant / Q000235:genetics / Q000378:metabolism; D004791:Enzyme Inhibitors / Q000494:pharmacology; D059585:G1 Phase Cell Cycle Checkpoints / Q000187:drug effects; D008164:Luminescent Proteins / Q000235:genetics / Q000378:metabolism; D008856:Microscopy, Fluorescence; D008870:Microtubules / Q000187:drug effects / Q000378:metabolism; D008898:Mimosine / Q000494:pharmacology; D009570:Nitriles / Q000494:pharmacology; D011687:Purines / Q000494:pharmacology; D000077546:Roscovitine; D053778:Thiazolidines / Q000494:pharmacology; D014026:Nicotiana / Q000166:cytology* / Q000235:genetics / Q000378:metabolism
D001549:Benzamides; D019086:Bridged Bicyclo Compounds, Heterocyclic; D018744:DNA, Plant; D004791:Enzyme Inhibitors; D008164:Luminescent Proteins; D009570:Nitriles; D011687:Purines; D053778:Thiazolidines; D000077546:Roscovitine; C001059:pronamide; D016590:Aphidicolin; D008898:Mimosine; C037068:latrunculin B; C055869:dichlobanil
Aphidicolin; BY-YTHCLR2 cells; Nuclear elongation; Nuclear positioning; Tobacco BY-2 cells